Search results
Pfizer Is Adding a Wall Street Analyst to Its C-Suite. What He Thinks the Company Needs to Do.
Barrons.com· 1 day agoHe also warned in January that sales of the company’s Prevnar vaccine franchise will fall in the...
Thousands Believe Covid Vaccines Harmed Them. Is Anyone Listening?
New York Times· 5 days agoWithin minutes of getting the Johnson & Johnson Covid-19 vaccine, Michelle Zimmerman felt pain...
Pfizer Stock Is Near An 11-Year Low — But Is It A Buy On This 'Massive' Upside?
Investor's Business Daily· 6 days agoPfizer Stock And Recent News Last month, Pfizer won FDA approval for Beqvez, its gene therapy for...
What to know about the new 'FLiRT' COVID variants that are spreading: Your guide to the latest virus...
Yahoo Life· 1 day agoHere’s your go-to guide with everything you need to know about COVID-19, including the latest...
Pfizer stock gains 7% after earnings beat, company calls dividend 'secure'
Yahoo Finance via AOL· 6 days agoPfizer also faces the expiration of patents on some of its biggest drugs, including breast cancer...
BioNTech's Outlook Gives Vaccine Maker a Shot in the Arm
Investopedia· 2 days agoThe German biotech firm, which collaborated with Pfizer (PFE) on a COVID-19 vaccine, reported a loss...
The true tragedy of the Covid-19 vaccines
The Telegraph via Yahoo News· 6 days agoVaccination is one of mankind’s most miraculous innovations. The eradication of smallpox, and the retreat of measles and other cruel afflictions, mean...
3 No-Brainer Stocks to Buy in May
Motley Fool via Yahoo Finance· 2 days agoThere are multiple metrics that help to highlight what kind of a deal Pfizer's stock is. It's trading at 12 times its estimated future profit and 1.7...
Biotech Breakthroughs: 7 Stocks Driving the Next Wave in Healthcare
InvestorPlace· 3 hours agoInvestors concerned about broader market undulations may want to consider the resilience narrative...
The top pharmaceutical companies by R&D expenditure
Pharmaceutical Technology via Yahoo Finance· 6 days agoWhile Pfizer scrapped some of its assets at the beginning of 2023,Pfizer expanded its ADC portfolio by completing the acquisition of Seagen for $43bn..
